Capecitabine, Panitumumab, and Radiation Therapy With or Without Irinotecan Hydrochloride in Treating Patients Undergoing Surgery for Localized Rectal Cancer
Clinical trial NCT00967655 · UNKNOWN
Trial details
- NCT number
- NCT00967655
- Sponsor
- Loma Linda Oncology Medical Group, Inc.
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-07-01
- Primary completion
- 2012-07-01
- Enrollment
- 54
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.